Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancerQipeng Liu, Qi Cao, Qiaqia Li et al.|International Journal of Cancer|2019Cited by 64
WBSCR22 confers oxaliplatin resistance in human colorectal cancerDongmei Yan, Xiaoju Wang|Scientific Reports|2017Cited by 49
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Ryan J. Rebernick et al.|Cell Reports Medicine|2024Cited by 28
Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levelsDongmei Yan, Xiaoju Wang|Molecular Medicine Reports|2014Cited by 7
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean C. Tien, Arul M. Chinnaiyan, Yali Zhai et al.|Proceedings of the National Academy of Sciences|2025Cited by 6